- Senior Program Officer at the U.S. Institute of Medicine
- Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
“The IOM report, Marijuana and Medicine: Assessing the Science Base, released in March 1999, found that marijuana’s active components are potentially effective in treating pain, nausea and vomiting, AIDS-related loss of appetite, and other symptoms and should be tested rigorously in clinical trials. The therapeutic effects of smoked marijuana are typically modest, and in most cases there are more effective medicines. But a subpopulation of patients do not respond well to other medications and have no effective alternative to smoking marijuana.”
Cowritten with John Benson and Stanley Watson, “From Marijuana to Medicine,” Issues in Science and Technology, Spring 1999
- Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
- Involvement and Affiliations:
- Senior Program Officer, Division on Neuroscience and Behavioral Health, U.S. Institute of Medicine
- Study Director, U.S. Institute of Medicine Report, 1999
- National Academy of Sciences: Intellectual Property issues, Neuroscience issues, and Environmental Management issues
- Post-doc, University of Texas
- Post-doc, Northwestern University
- PhD, University of Toronto
- Specialty: Neuroscience and Behavior
- Quoted in: